Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wenqing Jia
Institution:
Qilu Normal University
Observed institutions:
Qilu Normal University,
Tianjin Medical University
ORCID:
0000-0002-6974-3668
Observed ORCID:
0000-0002-6974-3668
OpenAlex ID:
A5103093051
Development of PI3Kα inhibitors for tumor therapy
2022
·
Wenqing Jia
, Shuyu Luo
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
20
Growth Inhibitory and Pro-Apoptotic Effects of Hirsuteine in Chronic Myeloid Leukemia Cells through Targeting Sphingosine Kinase 1
2022
·
Shan Gao
, Tingting Guo
, et al.
·
Biomolecules & Therapeutics
·
9
PDF
Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation
2024
·
Guangzhuang Li
, Sentao Xian
, et al.
·
Frontiers in Pharmacology
·
8
PDF
Discovery of Novel PI3Kδ Inhibitors Based on the p110δ Crystal Structure
2022
·
Wenqing Jia
, Shuyu Luo
, et al.
·
Molecules
·
8
PDF
In Silico Discovery of a Novel PI3Kδ Inhibitor Incorporating 3,5,7-Trihydroxychroman-4-one Targeting Diffuse Large B-Cell Lymphoma
2024
·
Wenqing Jia
, Jingdian Liu
, et al.
·
International Journal of Molecular Sciences
·
6
In Silico Discovery of a Novel Potential Allosteric PI3Kα Inhibitor Incorporating 3-(2-Chloro-5-fluorophenyl)isoindolin-1-one to Target Head and Neck Squamous Cell Carcinoma
2025
·
Wenqing Jia
, Xianchao Cheng
·
Biology
·
3
PDF
Targeting PI3Kδ for lymphoma and immune diseases treatment: a review
2026
·
Wenqing Jia
·
Molecular Diversity
·
1
In Silico Discovery of a Novel Natural Product Targeting PI3Kα for the Treatment of Head and Neck Squamous Cell Carcinoma
2025
·
Wenqing Jia
, Xianchao Cheng
·
International Journal of Molecular Sciences
·
1
PDF
In Silico Discovery of a Potential PI3Kα Inhibitor Incorporating an Imidazole Moiety for Breast Cancer Treatment
2026
·
Wenqing Jia
, Yukui Ma
, et al.
·
Current Issues in Molecular Biology
In Silico Evaluation via Virtual Screening, ADMET Profiling and Molecular Dynamics Simulations: Synthesis and Biological Activity Analysis of a Novel Antitumor PI3K Inhibitor
2026
·
Wenqing Jia
, Yukui Ma
, et al.
·
Biology
Targeting PI3Kα with Small Molecules: Progress and Challenges in Tumor Treatment
2026
·
Wenqing Jia
·
Current Issues in Molecular Biology
Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation
2025
·
Guangzhuang Li
, Sentao Xian
, et al.
·
Frontiers in Pharmacology
PDF
Show more works
View as search
Works count:
12
Citation count:
56
H-index:
5
I10-index:
1
Year
Topic
Type
